inspra 25 mg tabletti, kalvopäällysteinen
upjohn eesv - eplerenone - tabletti, kalvopäällysteinen - 25 mg - eplerenoni
inspra 50 mg tabletti, kalvopäällysteinen
upjohn eesv - eplerenone - tabletti, kalvopäällysteinen - 50 mg - eplerenoni
inspra 50 mg tabletti, kalvopäällysteinen
eplerenone - tabletti, kalvopäällysteinen - 50 mg - eplerenoni
inspra 25 mg tabletti, kalvopäällysteinen
eplerenone - tabletti, kalvopäällysteinen - 25 mg - eplerenoni
spironolactone mylan 25 mg tabletti, kalvopäällysteinen
mylan ab - spironolactonum - tabletti, kalvopäällysteinen - 25 mg - spironolaktoni
spironolactone mylan 50 mg tabletti, kalvopäällysteinen
mylan ab - spironolactonum - tabletti, kalvopäällysteinen - 50 mg - spironolaktoni
spironolactone mylan 100 mg tabletti, kalvopäällysteinen
mylan ab - spironolactonum - tabletti, kalvopäällysteinen - 100 mg - spironolaktoni
qaialdo
nova laboratories ireland limited - spironolaktoni - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 ja 5.
kaleorid 750 mg depottabletti
karo pharma ab - potassium chloride - depottabletti - 750 mg - kaliumkloridi
kaleorid 1 g depottabletti
karo pharma ab - potassium chloride - depottabletti - 1 g - kaliumkloridi